Protalix BioTherapeutics (PLX) Assets Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.49% |
| Dec 31, 2025 | 12.16% |
| Sep 30, 2025 | 33.63% |
| Jun 30, 2025 | -14.26% |
| Mar 31, 2025 | -17.74% |
| Dec 31, 2024 | -13.05% |
| Sep 30, 2024 | -29.70% |
| Jun 30, 2024 | 3.53% |
| Mar 31, 2024 | 34.96% |
| Dec 31, 2023 | 51.35% |
| Sep 30, 2023 | 54.42% |
| Jun 30, 2023 | 45.81% |
| Mar 31, 2023 | -2.68% |
| Dec 31, 2022 | -24.27% |
| Sep 30, 2022 | -32.07% |
| Jun 30, 2022 | -43.96% |
| Mar 31, 2022 | -33.47% |
| Dec 31, 2021 | 8.44% |
| Sep 30, 2021 | 15.45% |
| Jun 30, 2021 | 50.89% |
| Mar 31, 2021 | 24.03% |
| Dec 31, 2020 | 49.66% |
| Sep 30, 2020 | 34.58% |
| Jun 30, 2020 | 29.81% |
| Mar 31, 2020 | 35.76% |
| Dec 31, 2019 | -25.75% |
| Sep 30, 2019 | -18.28% |
| Jun 30, 2019 | 6.81% |
| Mar 31, 2019 | -5.79% |
| Dec 31, 2018 | -15.35% |
| Sep 30, 2018 | 7.68% |
| Jun 30, 2018 | -12.34% |
| Mar 31, 2018 | -9.82% |
| Dec 31, 2017 | -12.20% |
| Sep 30, 2017 | -13.36% |
| Jun 30, 2017 | -25.19% |
| Mar 31, 2017 | -17.70% |
| Dec 31, 2016 | -15.43% |
| Dec 31, 2015 | 24.12% |
| Dec 31, 2014 | -30.86% |
| Mar 31, 2014 | 47.86% |
| Dec 31, 2013 | 43.96% |
| Sep 30, 2013 | 56.58% |
| Jun 30, 2013 | -26.09% |
| Mar 31, 2013 | 2.16% |
| Dec 31, 2012 | 51.97% |
| Sep 30, 2012 | 27.21% |
| Jun 30, 2012 | 17.27% |
| Dec 31, 2011 | -19.97% |